Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SN-6 is an inhibitor of sodium-calcium exchanger 1 (NCX1; IC50 = 2.9 µM).1 It is selective for NCX1 over NCX2, NCX3, and sodium-potassium-calcium exchanger 2 (NCKX2; IC50s = 16, 8.6, and >30 µM, respectively) and a panel of 26 additional ion channels and receptors at 30 µM. SN-6 inhibits bidirectional inward and outward currents and unidirectional outward currents in whole-cell voltage-clamp assays using isolated guinea pig ventricular myocytes (IC50s = 1.9, 2.3, and 0.6 µM, respectively).2 It reduces hypoxia-reoxygenation-induced lactate dehydrogenase (LDH) release in LLC-PK1 porcine kidney epithelial cells overexpressing NCX1 (IC50 = 0.63 µM).1 In vivo, SN-6 (10 mg/kg) decreases ethanol intake and preference in female rats.3 It decreases the incidence of clonic and tonic-clonic seizures induced by pentylenetetrazole (PTZ; Item No. 18682) in rats when administered at doses ranging from 1 to 30 mg/kg.4
WARNING This product is not for human or veterinary use.
1. The exchanger inhibitory peptide region-
2. Characterization of SN-
3. Inhibition of the sodium-
4. Probing the role of the sodium/calcium exchanger in pentylenetetrazole-